10-13108850-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001008212.2(OPTN):c.-11-262T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0034 in 434,180 control chromosomes in the GnomAD database, including 19 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0076 ( 16 hom., cov: 31)
Exomes 𝑓: 0.0011 ( 3 hom. )
Consequence
OPTN
NM_001008212.2 intron
NM_001008212.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.183
Genes affected
OPTN (HGNC:17142): (optineurin) This gene encodes the coiled-coil containing protein optineurin. Optineurin may play a role in normal-tension glaucoma and adult-onset primary open angle glaucoma. Optineurin interacts with adenovirus E3-14.7K protein and may utilize tumor necrosis factor-alpha or Fas-ligand pathways to mediate apoptosis, inflammation or vasoconstriction. Optineurin may also function in cellular morphogenesis and membrane trafficking, vesicle trafficking, and transcription activation through its interactions with the RAB8, huntingtin, and transcription factor IIIA proteins. Alternative splicing results in multiple transcript variants encoding the same protein. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 10-13108850-T-C is Benign according to our data. Variant chr10-13108850-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 1197618.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00759 (1155/152114) while in subpopulation AFR AF= 0.0258 (1070/41506). AF 95% confidence interval is 0.0245. There are 16 homozygotes in gnomad4. There are 548 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 16 SD gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OPTN | NM_001008212.2 | c.-11-262T>C | intron_variant | ENST00000378747.8 | |||
OPTN | NM_001008211.1 | c.-80-112T>C | intron_variant | ||||
OPTN | NM_001008213.1 | c.-65-112T>C | intron_variant | ||||
OPTN | NM_021980.4 | c.-11-262T>C | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OPTN | ENST00000378747.8 | c.-11-262T>C | intron_variant | 1 | NM_001008212.2 | P3 |
Frequencies
GnomAD3 genomes AF: 0.00761 AC: 1156AN: 151996Hom.: 16 Cov.: 31
GnomAD3 genomes
AF:
AC:
1156
AN:
151996
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00114 AC: 321AN: 282066Hom.: 3 AF XY: 0.000943 AC XY: 143AN XY: 151584
GnomAD4 exome
AF:
AC:
321
AN:
282066
Hom.:
AF XY:
AC XY:
143
AN XY:
151584
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00759 AC: 1155AN: 152114Hom.: 16 Cov.: 31 AF XY: 0.00737 AC XY: 548AN XY: 74392
GnomAD4 genome
AF:
AC:
1155
AN:
152114
Hom.:
Cov.:
31
AF XY:
AC XY:
548
AN XY:
74392
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 17, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at